EirGen Pharma Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile
July 2017
18
About the Report
About the Report
Summary
EirGen Pharma Ltd (EirGen Pharma), a subsidiary of OPKO Health Inc is a pharmaceutical company that offers development, registration, manufacturing and supply of high-potency pharmaceutical products. The company offers services such as clinical trial management, drug formulation development, generic formulation development, cytotoxic product production and contract manufacturing services. It also develops and manufactures solid dosage forms; and produces a range of commercial soft gel oncology and high containment products. EirGen Pharma provides analytical laboratory and formulation development services. It supports complex projects at every stage from pre-formulation trials through formulation development to commercial supply. EirGen Pharma is headquartered in Waterford, Ireland.
EirGen Pharma Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
EirGen Pharma Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
EirGen Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
EirGen Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
EirGen Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
EirGen Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
EirGen Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
EirGen Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
EirGen Pharma Enters into Agreement with Equity Pharma 10
Acquisition 10
OPKO Health Acquires EirGen Pharma for USD135 Million 10
SPIMACO Acquires 48% Stake In EirGen Pharma, Manufacturer Of Cytotoxic Pharmaceutical Products, For USD25.3 Million 11
EirGen Pharma Ltd-Key Competitors 13
Key Employees 14
Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Legal and Regulatory 16
Mar 03, 2017: Eirgen Pharma Successfully Completes Pre-Approval Inspection With US FDA 16
Product News 17
Mar 17, 2017: Eirgen Pharma Product Eir-102 Passes Bioequivalence Study In US 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18
List of Figure
List of Figures
EirGen Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
EirGen Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
EirGen Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
EirGen Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
EirGen Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
EirGen Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
EirGen Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
EirGen Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
List of Table
List of Tables
EirGen Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts 1
EirGen Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
EirGen Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
EirGen Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
EirGen Pharma Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
EirGen Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
EirGen Pharma Enters into Agreement with Equity Pharma 10
OPKO Health Acquires EirGen Pharma for USD135 Million 10
SPIMACO Acquires 48% Stake In EirGen Pharma, Manufacturer Of Cytotoxic Pharmaceutical Products, For USD25.3 Million 11
EirGen Pharma Ltd, Key Competitors 13
EirGen Pharma Ltd, Key Employees 14
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.